Sayoko E Moroi. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Amides/therapeutic useAntihypertensive Agents/administration & dosageAntihypertensive Agents/therapeutic useAntineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useBimatoprostBreast Neoplasms/drug therapyBreast Neoplasms/radiotherapyCloprostenol/analogs & derivativesCloprostenol/therapeutic useCyclophosphamide/administration & dosageCyclophosphamide/adverse effectsDoxorubicin/administration & dosageDoxorubicin/adverse effectsEyelashes/drug effectsEyelashes/growth & developmentFemaleGlaucoma, Open-Angle/complicationsGlaucoma, Open-Angle/drug therapyHumansLatanoprostMiddle AgedOcular HypertensionOphthalmic SolutionsProstaglandins/administration & dosageProstaglandins/therapeutic useProstaglandins F, Synthetic/therapeutic useTravoprostTreatment Outcome
Substances： See more » AmidesAntihypertensive AgentsOphthalmic SolutionsProstaglandinsProstaglandins F, SyntheticCloprostenolLatanoprostDoxorubicinCyclophosphamideBimatoprostTravoprost
Year: 2010 PMID： 20660849 DOI： 10.1001/archinternmed.2010.247
Source DB: PubMed Journal: Arch Intern Med ISSN： 0003-9926